MORC-1 is a key component of the C. elegans CSR-1 germline gene licensing mechanism
Jessica A Kirshner,Colette L Picard,Natasha E Weiser,Nicita Mehta,Suhua Feng,Victoria N Murphy,Anna Vakhnovetsky,Amelia F Alessi,Connie Xiao,Kai Inoki,Sonia El Mouridi,Christian Frokjaer-Jensen,Steven E. Jacobsen,John K Kim
DOI: https://doi.org/10.1101/2024.10.02.616347
2024-10-02
Abstract:The Argonaute CSR-1 is essential for germline development in C. elegans. Mutation of csr-1 downregulates thousands of germline-expressed genes, leading to the model that the CSR-1-mediated small RNA pathway promotes, or "licenses," gene expression by an unknown mechanism. CSR-1 also silences a limited number of genes through its canonical endonucleolytic "slicer" activity. We show that the GHKL-type ATPase MORC-1, a CSR-1 slicing target, over-accumulates at CSR-1 "licensed" target genes in csr-1(-), which correlates with ectopic gain of H3K9me3, H3K36me3 loss, and gene downregulation. Loss of morc-1 rescues csr-1(-) defects, while overexpressing MORC-1 in the germline of wild-type worms is sufficient to cause sterility and downregulate CSR-1 targets. These results show that MORC-1 overexpression in csr-1(-) is a primary driver of the CSR-1-mediated gene licensing mechanism.
Molecular Biology